Different impact of factor VIII products on inhibitor development? - Wikidata - awgldk - TriplyDB

Different impact of factor VIII products on inhibitor development?

Different impact of factor VIII products on inhibitor development?

http://www.wikidata.org/entity/Q28075679

about

Predicting dose sparing benefit and bleeding risk of pharmacokinetic-based personalized prophylactic dosing of factor VIII products.

P2860

Q38764214-2D7A1604-5351-4399-9F1F-741C869A73AD

P2860

Different impact of factor VIII products on inhibitor development?

http://www.wikidata.org/entity/Q28075679

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Different impact of factor VIII products on inhibitor development?

@ast

Different impact of factor VIII products on inhibitor development?

@en

Different impact of factor VIII products on inhibitor development?

@nl

type

label

Different impact of factor VIII products on inhibitor development?

@ast

Different impact of factor VIII products on inhibitor development?

@en

Different impact of factor VIII products on inhibitor development?

@nl

prefLabel

Different impact of factor VIII products on inhibitor development?

@ast

Different impact of factor VIII products on inhibitor development?

@en

Different impact of factor VIII products on inhibitor development?

@nl

P1433

Q28075679-ADE3A5D4-E9B0-4268-9A86-6F6D6D3CFB46

P1476

Q28075679-9109B78D-A83F-4FB5-BB63-A5546707F38D

P2093

Q28075679-CABA2470-1E41-475C-8465-C5A83782EA43

P2860

Q28075679-07A276C4-546A-49BA-A87B-BECAC4CA7286

Q28075679-0C6A4224-AB3E-4D2D-82A6-824F833E888D

Q28075679-0EA44E52-AFD3-4759-9FFE-2125F11D06F4

Q28075679-0EB2CEC5-45C9-4512-85F6-0D4747B1C88C

Q28075679-1B913338-F1ED-4522-B0F9-122B9C840A6C

Q28075679-307D24C8-468E-4FB2-A735-C2CEE2B22515

Q28075679-3DF94FC4-E061-45D1-AE0F-3777C6CE2627

Q28075679-3E148925-D7C9-485D-B710-D42247E03359

Q28075679-473C77CE-DC60-4233-B771-20611D094815

Q28075679-51ECBE69-1C8B-40B7-BB28-3CED06125866

P2888

Q28075679-6D8DFADF-7A58-412C-ADC7-9FDE1AADD384

P304

Q28075679-71161F6D-C1B3-4924-93BA-8A01BC42BC76

P31

Q28075679-DB9CCAD1-0AFF-46AD-8B0F-17DB10B3720F

P3181

Q28075679-16DD3876-EAEB-45DD-A1A3-485F150EFF7E

P356

Q28075679-3B7DB2FA-8BC5-47BF-AB61-5ED8D423568D

P407

Q28075679-64C25049-4A6A-488B-ACE3-34B150CF2939

P433

Q28075679-E8AFD130-2D08-435F-83FD-2B1F83B37B48

P478

Q28075679-E336F57D-6090-4047-8386-2D7D25815D0C

P577

Q28075679-B7119ED0-6C66-4A5F-8ACA-F8DECD079417

P6179

Q28075679-78261066-A925-4DD1-BF76-FA6D1866B2E4

P698

Q28075679-9928ED92-F9DF-4396-9DE6-8D5F369FFC18

P932

Q28075679-0455B016-FBE2-4686-8ABB-46B90404FA2A

P3181

P356

S12959-016-0102-4

P1433

Thrombosis journal

P1476

Different impact of factor VIII products on inhibitor development?

@en

P2093

H. Marijke van den Berg

http://www.w3.org/2001/XMLSchema#string

P2860

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

FVIII inhibitors: pathogenesis and avoidance

The past and future of haemophilia: diagnosis, treatments, and its complications.

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.

The epidemiology of inhibitors in haemophilia A: a systematic review.

Genetic risk factors for inhibitors to factors VIII and IX.

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review.

Surgery and inhibitor development in hemophilia A: a systematic review.

P2888

s12959-016-0102-4

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3147384

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12959-016-0102-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029873402

http://www.w3.org/2001/XMLSchema#string

P698

27766057

http://www.w3.org/2001/XMLSchema#string

P932

5056474

http://www.w3.org/2001/XMLSchema#string